Bachrach L K, Katzman D K, Litt I F, Guido D, Marcus R
Department of Pediatrics, Stanford University School of Medicine, California.
J Clin Endocrinol Metab. 1991 Mar;72(3):602-6. doi: 10.1210/jcem-72-3-602.
Osteopenia is a frequent complication of anorexia nervosa (AN). To determine whether the deficit in bone mineral changes during the course of this illness, we studied 15 adolescent patients prospectively for 12-16 months using dual photon absorptiometry of the spine and whole body. At follow-up, mean weight, height, and body mass index (BMI) had increased significantly, although 6 girls had further weight loss or minimal gain (less than 1.2 kg). Spontaneous menses occurred in 2 girls, and 3 others were given estrogen replacement. Bone mineral density of the lumbar spine did not change significantly (mean +/- SD, 0.836 +/- 0.137 vs. 0.855 +/- 0.096 g/cm2), while whole body bone mineral density increased (0.710 +/- 0.118 vs. 0.773 +/- 0.105; P less than 0.05). Despite gains in bone mineral, 8 patients had osteopenia of the spine and/or whole body. Changes in weight, height, and BMI were significant predictors of change in bone mineral density. Increased bone mass occurred with weight gain before return of menses; conversely, weight loss was associated with further decreases in bone density. In 1 patient who failed to gain weight, estrogen therapy resulted in increased spinal, but not whole body, bone mineral. We also studied a second group of 9 women who had recovered from AN during adolescence. All 9 had normal whole body bone mineral for age, but 3 had osteopenia of the lumbar spine. We conclude that osteopenia in adolescents with AN reflects bone loss, perhaps combined with decreased bone accretion. Weight rehabilitation results in increased bone mineral before the return of menses. Estrogen may have an independent effect on bone mass. The persistence of osteopenia after recovery indicates that deficits in bone mineral acquired during adolescence may not be completely reversible.
骨质减少是神经性厌食症(AN)的常见并发症。为了确定在这种疾病过程中骨矿物质的缺乏是否会发生变化,我们对15名青少年患者进行了为期12至16个月的前瞻性研究,采用双能X线吸收法测量脊柱和全身的骨密度。随访时,平均体重、身高和体重指数(BMI)显著增加,尽管有6名女孩体重进一步减轻或增加极少(少于1.2千克)。2名女孩出现自发性月经,另外3名女孩接受了雌激素替代治疗。腰椎骨密度无显著变化(平均±标准差,0.836±0.137 vs. 0.855±0.096克/平方厘米),而全身骨密度增加(0.710±0.118 vs. 0.773±0.105;P<0.05)。尽管骨矿物质有所增加,但仍有8名患者存在脊柱和/或全身骨质减少。体重、身高和BMI的变化是骨密度变化的显著预测因素。月经恢复前体重增加时骨量增加;相反,体重减轻与骨密度进一步降低有关。在1名体重未增加的患者中,雌激素治疗导致脊柱骨矿物质增加,但全身骨矿物质未增加。我们还研究了第二组9名在青春期从AN中康复的女性。所有9名女性的全身骨矿物质含量在年龄上均正常,但3名女性存在腰椎骨质减少。我们得出结论,青少年AN患者的骨质减少反映了骨质流失,可能还伴有骨生长减少。体重恢复在月经恢复前导致骨矿物质增加。雌激素可能对骨量有独立影响。康复后骨质减少的持续存在表明青春期获得的骨矿物质缺乏可能不完全可逆。